A new verification link is sent. Check email. Resend confirmation email
BOTULAX 200u (Korean)
$349.00
| Quantity | Discount (%) | Price |
|---|---|---|
| 1 - 5 | — | $349.00 |
| 6 - 10 | 14.33 % | $299.00 |
| 11 - 20 | 17.19 % | $289.00 |
| 21+ | 20.06 % | $279.00 |
BOTULAX® 200u is a botulinum toxin type A injectable product developed by Hugel Inc. for both aesthetic and therapeutic applications. It is derived from Clostridium botulinum strain CBFC26 and acts by inhibiting acetylcholine release at the neuromuscular junction, resulting in targeted and temporary muscle paralysis. BOTULAX® is indicated for the treatment of benign essential blepharospasm and is widely used off-label for cosmetic indications such as dynamic facial lines. The product has been clinically validated through Phase III studies demonstrating non-inferiority to Botox® in efficacy and duration.
BOTULAX® 200u is manufactured in accordance with KFDA standards and features a vacuum-dried powder formulation requiring reconstitution prior to use. The effects typically begin within 3–5 days, peak at 1–2 weeks, and last for up to 3–4 months



